Results 251 to 260 of about 131,644 (347)

Prolonged Gastrointestinal Transit Times and Dysmotility in m.3243A>G Mitochondrial Disease

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
Carriers of m.3243A>G mitochondrial disease have impaired mitochondrial adenosine triphosphate (ATP) production. Our findings indicate that patients exhibit gastrointestinal dysmotility as assessed by the wireless motility capsule SmartPill. This indicates a critical role of mitochondrial ATP in normal gastrointestinal function.
Simone Rask Nielsen   +6 more
wiley   +1 more source

No Evidence for Unconscious Attentional Bias in People With Clinically Significant Symptoms of Functional Gastrointestinal Disorders: A Study Using the Emerging Electroencephalographic Paradigm of Fast Periodic Visual Stimulation

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
Fast Periodic Visual Stimulation (FPVS) is a brief behaviour‐free method with potential to capture unconscious attentional bias towards symptoms and negative stimuli in people with disorders of brain‐gut interaction. We compared a symptomatic group with a control group on FPVS indices and found no meaningful group differences, but make recommendations ...
Sarah McKerchar   +6 more
wiley   +1 more source

Evidence for Brain‐To‐Gut and Gut‐To‐Brain Pathways in Primary Care Patients With Disorders of Gut‐Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
Gut–brain pathways are bidirectional, but one pathway may predominate in certain disorders. The brain‐to‐gut pathway predominates in IBS, FD, and GERD, while a gut‐to‐brain disturbance dominates in overlap IBS/FD. Prior medications and gastroenteritis may indicate gut‐brain disturbances and may lead first to DGBI or GERD and later psychological ...
N. A. Koloski   +4 more
wiley   +1 more source

Impact of Enhanced Dietary Education Program on Gastrointestinal Symptoms in Patients With Functional Gastrointestinal Disorders: A Multicenter Prospective Pilot Study. [PDF]

open access: yesJ Neurogastroenterol Motil
Bang CS   +15 more
europepmc   +1 more source

Identifying Neural Patterns of Functional Dyspepsia Using Multivariate Pattern Analysis: A Resting-State fMRI Study

open access: gold, 2013
Peng Liu   +9 more
openalex   +2 more sources

Efficacy and Safety of the Enterosorbent Silicolgel in Irritable Bowel Syndrome, IBS‐D and IBS‐M: A Randomized, Double‐Blind, Placebo‐Controlled, Multi‐Center Trial

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
Current treatments often fall short in managing IBS effectively. Silicolgel, an enterosorbent, reduced IBS and other gastrointestinal symptoms in 90% of IBS patients compared to 20% in those on placebo. Enterosorbents are not currently recommended for IBS; silicolgel is a widely available, affordable option for patients with IBS‐D and IBS‐M.
O. Kuzminska   +3 more
wiley   +1 more source

Erratum: Gastric Emptying in Migraine: A Comparison With Functional Dyspepsia

open access: hybrid, 2013
Yeon Hwa Yu   +4 more
openalex   +2 more sources

Epidemiology of Meal‐Related Abdominal Discomfort or Pain in Irritable Bowel Syndrome

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
Seventy‐five percent of patients with Rome IV IBS experienced meal‐related abdominal discomfort or pain ≥ 50% of the time. Females, younger individuals, and those with comorbid functional dyspepsia and higher gastrointestinal symptom‐specific anxiety scores were more likely to report frequent meal‐related abdominal discomfort or pain. Recognizing these
Melanie S. Cuffe   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy